Coronary Stents Market in India 2014

Coronary Stents Market in India 2014

Netscribes’ latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types – those manufactured by MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies.

Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.
Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 - Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Oct 2013 - Mar 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Slide 5: Coronary stents - Uses, Characteristics and Types
Slide 6: Development of Coronary Stents

Market Overview
Slide 7: Angioplasties - Overview and Number of Procedures Performed in India (2008 - 2018e)
Slide 8: Angioplasties - Segmentation (Age-Wise; 2008 - 2013 & Gender-Wise; 2008 -2013)
Slide 9: Angioplasties - Segmentation (Based on Vessels Treated; 2009 - 2013 & Segregation of Centers Based on Number of Angioplasties Performed Each Year; 2009, 2010, 2011, 2013)
Slide 10: Coronary Stents - Market Overview, Market Size & Growth (Value-Wise; 2012 - 2018e & Volume-Wise; 2012 - 2018e)
Slide 11: Drug-Eluting Stents - Market Overview, Market Size & Growth (Value-Wise; 2012 - 2018e & Volume-Wise; 2012 - 2018e)
Slide 12: Bare Metal Stents - Market Overview, Market Size & Growth (Value-Wise; 2012 - 2018e & Volume-Wise; 2012 - 2018e)
Slide 13: Bioabsorbable Stents - Market Overview, Market Size & Growth (Value-Wise; 2013 - 2018e & Volume-Wise; 2013e - 2018e)
Slide 14: Coronary Stents - Price Trends

Drivers & Challenges
Slide 15: Drivers and Challenges - Summary
Slide 16-20: Drivers
Slide 21-22: Challenges

Government Involvement
Slide 23: Organizational Structure of Regulatory Bodies
Slide 24-25: Regulatory Bodies
Slide 26-29: Regulatory Policies
Slide 30: Process of Obtaining License for Manufacturing Medical Device Regulated as Drugs in India
Slide 31-33: Requirements for Grant of License for Manufacture of Medical Devices in India
Slide 34: Process of Obtaining Registration for Import of Medical Device Regulated as Drugs in India
Slide 35-39: Documents Required for the Registering Medical Devices for Import into India

Competitive Landscape
Slide 40-42: Entry Barriers
Slide 43: Porter's Five Forces Analysis
Slide 44: Competition Overview, Market Share of Companies (Volume-Wise; 2013)
Slide 45: Sale of Coronary Stents by Various Companies (2013)
Slide 46-49: Competitive Benchmarking
Slide 50-98: Major Companies

Buyer Details
Slide 99: List of Top 10 Hospitals Buying Coronary Stents in India
Slide 100-129: Major Buyers
Slide 130: Other Major Purchasers of Stents

Recent Developments
Slide 131: Major Recent Developments in the Market

Strategic Recommendation
Slide 132-133: Key Recommendations
Slide 134: Opportunities by Geography

Slide 135: Key Ratios Description
Slide 136: Sources of Information